HNGE PE Ratio & Valuation,Is HNGE Overvalued — Intellectia
HNGE Relative Valuation
HNGE's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, HNGE is overvalued; if below, it's undervalued.
Historical Valuation
Hinge Health Inc(HNGE) is now in theFairzone, suggesting that its currentforward PEratio of31.51is consideredFairlycompared with the five-year average of44.65.The fair price ofHinge Health Inc(HNGE)is between40.83to104.12according to relative valuation methord.
Relative Value
Fair Zone
40.83-104.12
Current Price：48.41
Fair
31.51
PE
1Y
3Y
5Y
Trailing
Forward
25.37
EV/EBITDA
Hinge Health Inc. (HNGE) has a current EV/EBITDA of 25.37. The 5-year average EV/EBITDA is 39.53. The thresholds are as follows: Strongly Undervalued below -19.03, Undervalued between -19.03 and 10.25, Fairly Valued between 68.81 and 10.25, Overvalued between 68.81 and 98.10, and Strongly Overvalued above 98.10. The current Forward EV/EBITDA of 25.37 falls within the Historic Trend Line -Fairly Valued range.
27.67
EV/EBIT
Hinge Health Inc. (HNGE) has a current EV/EBIT of 27.67. The 5-year average EV/EBIT is 46.31. The thresholds are as follows: Strongly Undervalued below -29.21, Undervalued between -29.21 and 8.55, Fairly Valued between 84.07 and 8.55, Overvalued between 84.07 and 121.83, and Strongly Overvalued above 121.83. The current Forward EV/EBIT of 27.67 falls within the Historic Trend Line -Fairly Valued range.
5.73
PS
Hinge Health Inc. (HNGE) has a current PS of 5.73. The 5-year average PS is 5.80. The thresholds are as follows: Strongly Undervalued below 1.86, Undervalued between 1.86 and 3.83, Fairly Valued between 7.77 and 3.83, Overvalued between 7.77 and 9.75, and Strongly Overvalued above 9.75. The current Forward PS of 5.73 falls within the Historic Trend Line -Fairly Valued range.
21.45
P/OCF
Hinge Health Inc. (HNGE) has a current P/OCF of 21.45. The 5-year average P/OCF is 26.55. The thresholds are as follows: Strongly Undervalued below 2.87, Undervalued between 2.87 and 14.71, Fairly Valued between 38.40 and 14.71, Overvalued between 38.40 and 50.24, and Strongly Overvalued above 50.24. The current Forward P/OCF of 21.45 falls within the Historic Trend Line -Fairly Valued range.
24.10
P/FCF
Hinge Health Inc. (HNGE) has a current P/FCF of 24.10. The 5-year average P/FCF is 28.75. The thresholds are as follows: Strongly Undervalued below 5.35, Undervalued between 5.35 and 17.05, Fairly Valued between 40.45 and 17.05, Overvalued between 40.45 and 52.15, and Strongly Overvalued above 52.15. The current Forward P/FCF of 24.10 falls within the Historic Trend Line -Fairly Valued range.
Hinge Health Inc (HNGE) has a current Price-to-Book (P/B) ratio of 18.32. Compared to its 3-year average P/B ratio of 16.85 , the current P/B ratio is approximately 8.76% higher. Relative to its 5-year average P/B ratio of 16.85, the current P/B ratio is about 8.76% higher. Hinge Health Inc (HNGE) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 2.94%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 2.94% , the current FCF yield is about -100.00% lower.
18.32
P/B
Median3y
16.85
Median5y
16.85
3.81
FCF Yield
Median3y
2.94
Median5y
2.94
Competitors Valuation Multiple
The average P/S ratio for HNGE's competitors is , providing a benchmark for relative valuation. Hinge Health Inc Corp (HNGE) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 53.27%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of HNGE increased by 24.64% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -0.82 to -4.29.
The secondary factor is the Revenue Growth, contributed 53.27%to the performance.
Overall, the performance of HNGE in the past 1 year is driven by P/E Change. Which is more unsustainable.
Is Hinge Health Inc (HNGE) currently overvalued or undervalued?
Hinge Health Inc(HNGE)is now in theFairzone, suggesting that its currentforward PEratio of 31.51is consideredFairlycompared with the five-year average of44.65.The fair price of Hinge Health Inc(HNGE)is between40.83to104.12according to relative valuation methord.
What is Hinge Health Inc (HNGE) fair value?
HNGE's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Hinge Health Inc (HNGE) is between 40.83to104.12 according to relative valuation methord.
How does HNGE's valuation metrics compare to the industry average?
The average P/S ratio for HNGE's competitors is , providing a benchmark for relative valuation. Hinge Health Inc Corp (HNGE) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 53.27%, this premium appears sustainable.
What is the current P/B ratio for Hinge Health Inc (HNGE) as of Dec 17 2025?
As of Dec 17 2025, Hinge Health Inc (HNGE) has a P/B ratio of 18.32. This indicates that the market values HNGE at 18.32 times its book value.
What is the current FCF Yield for Hinge Health Inc (HNGE) as of Dec 17 2025?
As of Dec 17 2025, Hinge Health Inc (HNGE) has a FCF Yield of 0.00%. This means that for every dollar of Hinge Health Inc’s market capitalization, the company generates 0.00 cents in free cash flow.
What is the current Forward P/E ratio for Hinge Health Inc (HNGE) as of Dec 17 2025?
As of Dec 17 2025, Hinge Health Inc (HNGE) has a Forward P/E ratio of 31.51. This means the market is willing to pay $31.51 for every dollar of Hinge Health Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Hinge Health Inc (HNGE) as of Dec 17 2025?
As of Dec 17 2025, Hinge Health Inc (HNGE) has a Forward P/S ratio of 0.00. This means the market is valuing HNGE at $0.00 for every dollar of expected revenue over the next 12 months.
